Purchases and Sales Made in Q1 2024 in Monopar Therapeutics (MNPR)
This table provides information about the institutional ownership of Monopar Therapeutics (MNPR) during Q1 2024. The information is specifically focused on institutions that hold shares of Monopar Therapeutics.
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
May 15, 2024
Q1 2024
|
Israel Englander
Millennium Management LLC | New York, Ny
|
BUY
|
- |
163K+ 555.67% |
$50.5K - $220K
|
192K
$9.32M
|
|
May 13, 2024
Q1 2024
|
Hrt Financial LP
New York, NY |
BUY
|
- |
32.1KNew |
$9.96K - $43.4K
|
32.1K
$1.56M
|
|
May 15, 2024
Q1 2024
|
Tower Research Capital LLC (Trc)
New York, NY |
BUY
|
- |
4.24K+ 117.14% |
$1.31K - $5.72K
|
7.86K
$381K
|
|
May 14, 2024
Q1 2024
|
New Edge Advisors, LLC
New Orleans, LA |
BUY
|
- |
3KNew |
$930 - $4.05K
|
3K
$145K
|
|
May 10, 2024
Q1 2024
|
Wells Fargo & Company
San Francisco, CA |
BUY
|
- |
1.5K+ 4054.05% |
$465 - $2.03K
|
1.54K
$74.5K
|
|
Oct 17, 2024
Q1 2024
|
Morgan Stanley
New York, NY |
BUY
|
- |
800New |
$248 - $1.08K
|
800
$38.8K
|
|
May 15, 2024
Q1 2024
|
Bank Of America Corp
Charlotte, NC |
BUY
|
- |
500New |
$155 - $675
|
500
$24.2K
|
|
Nov 05, 2024
Q1 2024
|
Royal Bank Of Canada
Toronto, A6 |
BUY
|
- |
100New |
$31 - $135
|
100
$4.85K
|
|
May 15, 2024
Q1 2024
|
Royal Bank Of Canada
Toronto, A6 |
BUY
|
- |
100New |
$31 - $135
|
100
$4.85K
|
|
May 15, 2024
Q1 2024
|
Federation Des Caisses Desjardins Du Quebec
Levis, A8 |
BUY
|
- |
80New |
$24.8 - $108
|
80
$3.88K
|
|
Apr 30, 2024
Q1 2024
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
May 20, 2024
Q1 2024
|
Virtu Financial LLC
New York, NY |
SELL
|
- |
-3.34K- 12.3% |
$1.04K - $4.51K
|
23.8K
$1.15M
|
|
May 13, 2024
Q1 2024
|
Ubs Group Ag
|
SELL
|
- |
-9.33K- 78.42% |
$2.89K - $12.6K
|
2.57K
$124K
|